Insider · CIK 0001238648

DUNN JOHN MICHAEL

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001238648

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-11-17	Acer Therapeutics Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−27.4K sh	—	—	0
2023-03-14	Acer Therapeutics Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-01-14	Acer Therapeutics Inc.Stock Option (right to buy)A Award	Director	AAward	+18.5K sh	—	—	18,500
2021-01-15	Acer Therapeutics Inc.Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2020-07-24	Acer Therapeutics Inc.P Purchase	Director	PPurchase	+21.4K sh	$3.50	+$75K	27,380
2020-01-02	Acer Therapeutics Inc.Stock Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2019-02-01	Acer Therapeutics Inc.Employee Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2019-01-11	IMUXIMMUNIC, INC. · Restricted Stock UnitsA Award	General Counsel and Secretary	AAward	+725K sh	—	—	724,848
2019-01-11	IMUXIMMUNIC, INC. · Stock Option (right to buy)D Disposition to Issuer	General Counsel and Secretary	DDisposition to Issuer	−45K sh	—	—	0
2019-01-11	IMUXIMMUNIC, INC. · Stock Option (right to buy)D Disposition to Issuer	General Counsel and Secretary	DDisposition to Issuer	−45K sh	—	—	0
2019-01-11	IMUXIMMUNIC, INC. · Stock Option (right to buy)D Disposition to Issuer	General Counsel and Secretary	DDisposition to Issuer	−45K sh	—	—	0
2019-01-11	IMUXIMMUNIC, INC. · Stock Option (right to buy)D Disposition to Issuer	General Counsel and Secretary	DDisposition to Issuer	−50K sh	—	—	0
2018-06-09	IMUXIMMUNIC, INC. · Stock Option (right to buy)A Award	General Counsel and Secretary	AAward	+45K sh	—	—	45,000
2017-10-04	Acer Therapeutics Inc.Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2017-09-19	Acer Therapeutics Inc.Nonqualified Stock Option (right to buy)J Other	Director	JOther	+16K sh	—	—	16,000
2017-09-19	Acer Therapeutics Inc.J Other	Director	JOther	+5,952 sh	—	—	5,952
2017-06-14	IMUXIMMUNIC, INC.P Purchase	General Counsel and Secretary	PPurchase	+100 sh	$3.08	+$307.5	9,485
2017-06-14	IMUXIMMUNIC, INC.P Purchase	General Counsel and Secretary	PPurchase	+2,400 sh	$3.09	+$7,416.96	11,885
2017-06-10	IMUXIMMUNIC, INC. · Stock Option (right to buy)A Award	General Counsel and Secretary	AAward	+45K sh	—	—	45,000
2016-05-13	IMUXIMMUNIC, INC. · Stock Option (right to buy)A Award	General Counsel and Secretary	AAward	+45K sh	—	—	45,000
2015-10-26	IMUXIMMUNIC, INC.P Purchase	General Counsel and Secretary	PPurchase	+2,000 sh	$7.00	+$14K	9,385
2015-10-23	IMUXIMMUNIC, INC.P Purchase	General Counsel and Secretary	PPurchase	+7,385 sh	$6.76	+$49.9K	7,385
2014-11-17	IMUXIMMUNIC, INC. · Stock Option (right to buy)A Award	General Counsel and Secretary	AAward	+50K sh	—	—	50,000
2009-02-24	BIIBBIOGEN INC.A Award	EVP, New Ventures	AAward	+6,040 sh	—	—	24,752.402
2009-02-24	BIIBBIOGEN INC. · Stock Option (Right to Buy)A Award	EVP, New Ventures	AAward	+16.1K sh	—	—	16,070
2009-02-19	BIIBBIOGEN INC.S Sale	EVP, New Ventures	SSale	−3,208 sh	$50.90	−$163K	18,712.402
2009-02-12	BIIBBIOGEN INC.F Tax Payment	EVP, New Ventures	FTax Payment	−1,244 sh	$52.61	−$65.4K	23,712.402
2009-02-12	BIIBBIOGEN INC.F Tax Payment	EVP, New Ventures	FTax Payment	−1,792 sh	$52.61	−$94.3K	21,920.402
2009-02-11	BIIBBIOGEN INC.S Sale	EVP, New Ventures	SSale	−2,258 sh	$50.81	−$115K	24,956.402
2009-02-06	BIIBBIOGEN INC.M Exercise/Conversion	EVP, New Ventures	MExercise/Conversion	+3,633 sh	—	—	28,589.402
2009-02-06	BIIBBIOGEN INC.F Tax Payment	EVP, New Ventures	FTax Payment	−1,375 sh	$52.48	−$72.2K	27,214.402
2009-02-06	BIIBBIOGEN INC. · Restricted Stock UnitM Exercise/Conversion	EVP, New Ventures	MExercise/Conversion	−3,633 sh	—	—	0
2008-07-29	BIIBBIOGEN INC.G Gift	EVP, New Ventures	GGift	−32 sh	—	—	24,956.402
2008-07-22	BIIBBIOGEN INC.S Sale	EVP, New Ventures	SSale	−6,485 sh	$71.50	−$464K	24,988.402
2008-07-22	BIIBBIOGEN INC. · Stock Option (right to buy)M Exercise/Conversion	EVP, New Ventures	MExercise/Conversion	−6,485 sh	—	—	0
2008-07-22	BIIBBIOGEN INC.M Exercise/Conversion	EVP, New Ventures	MExercise/Conversion	+6,485 sh	$43.50	+$282K	31,473.402
2007-06-27	BIIBBIOGEN INC.M Exercise/Conversion	EVP, New Ventures	MExercise/Conversion	+15.4K sh	$35.37	+$543K	32,981.07
2007-06-27	BIIBBIOGEN INC. · Stock Option (right to buy)M Exercise/Conversion	EVP, New Ventures	MExercise/Conversion	−15.4K sh	—	—	0
2007-06-27	BIIBBIOGEN INC.S Sale	EVP, New Ventures	SSale	−15.4K sh	$52.90	−$812K	17,629.07
2007-04-23	BIIBBIOGEN INC. · Stock Option (right to buy)M Exercise/Conversion	EVP, New Ventures	MExercise/Conversion	−15K sh	—	—	15,352
2007-04-23	BIIBBIOGEN INC.S Sale	EVP, New Ventures	SSale	−18.8K sh	$48.90	−$917K	17,629.07
2007-04-23	BIIBBIOGEN INC.M Exercise/Conversion	EVP, New Ventures	MExercise/Conversion	+15K sh	$35.37	+$531K	36,389.07
2007-04-20	BIIBBIOGEN INC.S Sale	EVP, New Ventures	SSale	−2,328 sh	$46.02	−$107K	26,580.07
2007-04-20	BIIBBIOGEN INC.S Sale	EVP, New Ventures	SSale	−1,431 sh	$46.06	−$65.9K	21,389.07
2007-04-20	BIIBBIOGEN INC.S Sale	EVP, New Ventures	SSale	−1,431 sh	$46.00	−$65.8K	22,820.07
2007-04-20	BIIBBIOGEN INC.S Sale	EVP, New Ventures	SSale	−2,329 sh	$45.99	−$107K	24,251.07
2005-02-17	BIIBBIOGEN INC. · Stock Option (right-to-buy)A Award	EVP, New Ventures	AAward	+60K sh	—	—	60,000
2004-12-09	BIIBBIOGEN INC.M Exercise/Conversion	EVP, New Ventures	MExercise/Conversion	+5,000 sh	$35.37	+$177K	58,202
2004-12-09	BIIBBIOGEN INC. · Stock Option (right-to-buy)M Exercise/Conversion	EVP, New Ventures	MExercise/Conversion	−5,000 sh	—	—	53,202
2004-12-09	BIIBBIOGEN INC.S Sale	EVP, New Ventures	SSale	−5,000 sh	$65.00	−$325K	53,202

Recent filings

Accepted (ET)
Nov 204
DUNN JOHN MICHAEL0000899243-23-020443
SEC(opens sec.gov)
Mar 164
DUNN JOHN MICHAEL0001209191-23-019314
SEC(opens sec.gov)
Jan 194
DUNN JOHN MICHAEL0001209191-22-003715
SEC(opens sec.gov)
Jan 204
DUNN JOHN MICHAEL0001209191-21-004268
SEC(opens sec.gov)
Jul 284
DUNN JOHN MICHAEL0001209191-20-043804
SEC(opens sec.gov)
Jan 34
DUNN JOHN MICHAEL0001209191-20-000887
SEC(opens sec.gov)
Feb 54
DUNN JOHN MICHAEL0001209191-19-007240
SEC(opens sec.gov)
Jan 144
DUNN JOHN MICHAEL0001280776-19-000015
SEC(opens sec.gov)
Jun 114
DUNN JOHN MICHAEL0001280776-18-000068
SEC(opens sec.gov)
Oct 64
DUNN JOHN MICHAEL0001654954-17-009222
SEC(opens sec.gov)
Sep 214
DUNN JOHN MICHAEL0001654954-17-008688
SEC(opens sec.gov)
Jun 154
VITAL THERAPIES INC0001280776-17-000075
SEC(opens sec.gov)
Jun 134
VITAL THERAPIES INC0001280776-17-000064
SEC(opens sec.gov)
May 174
VITAL THERAPIES INC0001628280-16-016453
SEC(opens sec.gov)

Companies

Address

14 CAMBRIDGE CENTER

CAMBRIDGE, MA, 02142